Article metrics
PDF
Other content recommended for you
- Disease-modifying therapies for multiple sclerosis
- Fertility, pregnancy and childbirth in women with multiple sclerosis: a population-based study from 2018 to 2020
- Multiple sclerosis and the risk of infection: Association of British Neurologists consensus guideline
- Association of British Neurologists: revised (2015) guidelines for prescribing disease-modifying treatments in multiple sclerosis
- Disease modification in multiple sclerosis: an update
- Update on disease-modifying therapies for multiple sclerosis
- Effectiveness of multiple disease-modifying therapies in relapsing-remitting multiple sclerosis: causal inference to emulate a multiarm randomised trial
- Disease modifying therapies for relapsing multiple sclerosis
- Pharmacovigilance during treatment of multiple sclerosis: early recognition of CNS complications
- Vaccination and multiple sclerosis in the era of the COVID-19 pandemic